SCS Capital Management LLC Invests $7.21 Million in HCA Healthcare, Inc. $HCA

Key Points

• SCS Capital Management purchased 18,480 shares of HCA Healthcare during the second quarter, valued at approximately $7.21 million. Institutional investors collectively own 62.73% of the company.
• HCA reported quarterly earnings of $7.59 per share, slightly exceeding estimates, while revenue rose 8.7% year over year to $20.23 billion.
• HCA declared a quarterly dividend of $0.78 per share, equivalent to an annualized $3.12 payout and a 0.8% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $465.59.

SCS Capital Management LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 18,480 shares of the company's stock, valued at approximately $7,205,000.

A number of other institutional investors have also made changes to their positions in the business. Palisade Asset Management LLC bought a new position in HCA Healthcare in the third quarter valued at $26,000. Ares Financial Consulting LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $31,000. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $33,000. MCF Advisors LLC boosted its position in HCA Healthcare by 213.0% during the fourth quarter. MCF Advisors LLC now owns 72 shares of the company's stock valued at $34,000 after purchasing an additional 49 shares during the last quarter. Finally, Clearstead Trust LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $29,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $404.61 on Monday. The firm's 50-day simple moving average is $393.41 and its 200 day simple moving average is $446.61. The firm has a market cap of $87.60 billion, a P/E ratio of 13.55, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm's revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.84 earnings per share. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HCA. Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. Leerink Partners decreased their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating for the company in a research report on Monday, April 27th. The Goldman Sachs Group cut their target price on shares of HCA Healthcare from $558.00 to $485.00 and set a "buy" rating for the company in a research note on Tuesday, July 28th. Robert W. Baird dropped their price objective on HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a research note on Monday, July 27th. Finally, Sanford C. Bernstein reiterated a "market perform" rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $465.59.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source